References
-
1) Mild hyperhomocysteinemia induces blood–brain barrier dysfunction but not neuroinflammation in the cerebral cortex and hippocampus of wild-type mice.
Product: Claudin 5 Antibody (#AF5216)Year: 2021Journal: Can J Physiol PharmacolImpactFactor: 1.7DOI: 10.1139/cjpp-2020-0507PMID: 34161158 -
2) Water treadmill training protects the integrity of the blood-spinal cord barrier following SCI via the BDNF/TrkB-CREB signalling pathway.
Product: Claudin 5 Antibody (#AF5216)Year: 2021Journal: NEUROCHEM INTImpactFactor: 4.4DOI: 10.1016/j.neuint.2020.104945PMID: 33359781 -
3) Asiatic acid attenuates diabetic retinopathy through TLR4/MyD88/NF-κB p65 mediated modulation of microglia polarization.
Product: Claudin 5 Antibody (#AF5216)Year: 2021Journal: Life SciImpactFactor: 5.2DOI: 10.1016/j.lfs.2021.119567PMID: 33965378 -
4) DL0410 Alleviates Memory Impairment in D-Galactose-Induced Aging Rats by Suppressing Neuroinflammation via the TLR4/MyD88/NF-κB Pathway.
Product: Claudin 5 Antibody (#AF5216)Year: 2021Journal: Oxid Med Cell LongevDOI: 10.1155/2021/6521146PMID: 34650664 -
5) LXA4 protects against hypoxic-ischemic damage in neonatal rats by reducing the inflammatory response via the IκB/NF-κB pathway.
Product: Claudin 5 Antibody (#AF5216)Year: 2020Journal: INT IMMUNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.intimp.2020.107095PMID: 33096360 -
6) Improvement of autophagy dysfunction as a potential mechanism for environmental enrichment to protect blood-brain barrier in rats with vascular cognitive impairment.
Product: Claudin 5 Antibody (#AF5216)Year: 2020Journal: NEUROSCI LETTImpactFactor: 2.5DOI: 10.1016/j.neulet.2020.135437PMID: 33132180 -
7) Icariside II attenuates cerebral ischemia/reperfusion-induced blood–brain barrier dysfunction in rats via regulating the balance of MMP9/TIMP1.
Product: Claudin 5 Antibody (#AF5216)Year: 2020Journal: ACTA PHARMACOL SINImpactFactor: 6.9DOI: 10.1038/s41401-020-0409-3PMID: 32488170 -
8) XQ-1H regulates Wnt/GSK3β/β-catenin pathway and ameliorates the integrity of blood brain barrier in mice with acute ischemic stroke.
Product: Claudin 5 Antibody (#AF5216)Year: 2020Journal: BRAIN RES BULLImpactFactor: 3.5DOI: 10.1016/j.brainresbull.2020.08.032PMID: 32916221 -
9) Protective Effects of the Soluble Epoxide Hydrolase Inhibitor 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea in a Rat Model of Permanent Middle Cerebral Artery Occlusion.
Product: Claudin 5 Antibody (#AF5216)Year: 2020Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2020.00182PMID: 32184732 -
10) MiR-429 regulates blood-spinal cord barrier permeability by targeting Krüppel-like factor 6.
Product: Claudin 5 Antibody (#AF5216)Year: 2020Journal: BIOCHEM BIOPH RES COImpactFactor: 2.5DOI: 10.1016/j.bbrc.2020.02.138PMID: 32145913 -
11) Scutellarin-treated exosomes increase claudin 5, occludin and ZO1 expression in rat brain microvascular endothelial cells.
Product: Claudin 5 Antibody (#AF5216)Year: 2019Journal: EXP THER MEDImpactFactor: 2.4DOI: 10.3892/etm.2019.7562PMID: 31258635 -
12) A novel IL-1RA-PEP fusion protein alleviates blood-brain barrier disruption after ischemia-reperfusion in male rats.
Product: Claudin 5 Antibody (#AF5216)Year: 2018Journal: J NeuroinflammationImpactFactor: 9.3DOI: 10.1186/s12974-018-1058-zPMID: 29334965 -
13) Downregulation of CLDN6 inhibits cell migration and invasion and promotes apoptosis by regulation of the JAK2/STAT3 signaling pathway in hepatocellular carcinoma.
Product: Claudin 6 Antibody (#AF5213)Year: 2023Journal: Transl Cancer ResImpactFactor: 1.5DOI: 10.21037/tcr-23-19PMID: 37588735 -
14) Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma.
Product: Claudin 6 Antibody (#AF5213)Year: 2022Journal: STAR ProtocolsImpactFactor: 1.3DOI: 10.1016/j.xpro.2022.101921PMID: 36595904 -
15) The Curcumin Derivative, H10, Suppresses Hormone-Dependent Prostate Cancer by Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3.